Effects of enoximone on right-ventricular function in patients with impaired myocardial performance.
The effects of an enoximone monotherapy on left-ventricular and especially on right-ventricular haemodynamics were investigated in fourteen patients with impaired left-ventricular function secondary to coronary artery disease. Anaesthesia was induced and maintained with fentanyl and flunitrazepam. After reaching steady state, a bolus of 0.5 mg/kg enoximone was administered, followed by an infusion of 0.5 microgram/kg/min. Besides the common haemodynamic parameters particulary the right-ventricular ejection fraction (RVEF) was measured using a special thermodilution technique. The predefined time points were: before administration of enoximone (baseline) and 5 min, 10 min, 15 min, 20 min, and 30 min after bolus injection of enoximone. Compared to the baseline the maximum effects of enoximone were a 28% increase of cardiac index accompanied by a 39% decline of systemic vascular resistance and an unchanged left-ventricular stroke-work index. While central venous pressure and mean pulmonary artery pressure remained unchanged. RVEF (+20%) and right-ventricular stroke-work index (+30%) were significantly augmented, augmented, indicating improved right-ventricular performance. No adverse effects of the enoximone administration were observed perioperatively. We conclude that an enoximone monotherapy is beneficial for patients with impaired myocardial function undergoing cardiac surgery.